Investing in Anti-Aging Biotech Stocks
About 12 years ago, I decided to go vegan.
Not for ethical or even health reasons –– I really just wanted to try it.
I wanted to see what would happen...
I wanted to experiment with new recipes within the confines of dietary restrictions.
I wanted to see how it would affect my health, my mood, and my overall outlook on food...
Truth is, it wasn’t bad.
I actually enjoyed much of the food that I made, some of which I still make to this day. I’m a huge fan of Japanese winter stew, which is a hearty vegan meal that really hits the spot on a cold day.
But I did end up eschewing the vegan diet for one that’s more of a healthy balance of meat, dairy, vegetables, fruit, and grains –– it just works for me. It gives me the nutrition I need to maintain my strict fitness regimen and sustain what I believe is optimal health.
Of course, everyone’s body chemistry is different.
For some, my diet, which is high in healthy fat and meat-based protein, may not work. For others, it may work great.
A good friend of mine is actually a registered dietician, and she and I talk about this a lot.
She tells me the biggest request she gets is for meal plans that will help her patients slow or reverse the aging process.
Certainly, while there is no diet that can allow you to live forever, there are some things you can do to ensure that the food you’re eating doesn’t degrade your health, thereby speeding up the aging process.
For her, clean eating is paramount: no processed foods, plenty of raw organic fruits and vegetables, healthy fats, meat-based protein (sourced from farms that employ regenerative farming practices), and no refined sugar.
But even with a proper diet and exercise, she’ll still tell you that there is no diet in existence that can stop senescent cells from accumulating in your body.
If you’re unfamiliar, senescent cells accumulate in your body as you age, and they secrete large quantities of harmful proteins that cause inflammation and tissue degradation. The result is aging and age-related diseases.
Certainly, scientists have been studying this for decades, and there are plenty of registered dietitians, including my friend, who would love nothing more than to discover the perfect diet to counter the effects of cell senescence.
But, the closest thing we have today to such a thing is a new class of anti-aging drugs known as senolytics. And there’s really only one company that’s made any real headway on this.
Our analysts have traveled the world over, dedicated to finding the best and most profitable investments in the global energy markets. All you have to do to join our Energy and Capital investment community is sign up for the daily newsletter below.
The “Fountain of Youth” Comes in a Pill
Some have called it the most undervalued stock in the biotech space...
Others have called it the most undervalued stock, period.
After all, the company that’s developing these drugs is essentially creating a cure for aging by removing senescent cells –– something that’s never been done before in humans, but something that, if proven successful, could completely disrupt the health care industry forever.
Imagine a health care industry that no longer had to treat age-related diseases because the cause of those diseases could effectively be removed.
The value of such a drug would be superior to any drug available on the market today: opioids, allergy medications, even boner pills.
We’re talking about a drug that could allow us all to live longer lives and without most diseases that come with aging.
Of course, there’s no guarantee that the company developing these drugs will be successful. It could end up being a bust.
But right now, this company is conducting clinical trials, and early results look promising. If this does end up hitting, this stock could easily double overnight. And while I’m not a huge gambler, I do understand the basic fundamentals of a risk versus reward scenario.
And the reward for a company that could virtually end all age-related diseases? That’s just a no-brainer.
I’ve personally been profiting from this company’s work in the field of senolytics, and I would encourage you to do the same.
Here’s a link to a report that explains how the drug works, and here’s a link to a report I wrote that tells you more about the company, the drugs it's currently developing, and a list of some of the folks who have already invested in this company –– including Amazon CEO Jeff Bezos.
Yeah, this is a no-brainer.
To a new way of life and a new generation of wealth...
@JeffSiegel on Twitter
Jeff is the founder and managing editor of Green Chip Stocks, a private investment community that capitalizes on opportunities in alternative energy, organic food markets, legal cannabis, and socially responsible investing. He has been a featured guest on Fox, CNBC, and Bloomberg Asia, and is the author of the best-selling book, Investing in Renewable Energy: Making Money on Green Chip Stocks. For more on Jeff, go to his editor's page.
Energy Demand will Increase 58% Over the Next 25 Years
After getting your report, you’ll begin receiving the Energy and Capital e-Letter, delivered to your inbox daily.